-
公开(公告)号:US20190144442A1
公开(公告)日:2019-05-16
申请号:US16186018
申请日:2018-11-09
Applicant: The Regents of the University of Michigan
Inventor: Jolanta Grembecka , Szymon Klossowski , Jing Deng , Tomasz Cierpicki , Hao Li , Hongzhi Miao , Trupta Purohit , EunGi Kim
IPC: C07D471/04 , A61K9/00 , A61P35/02 , A61K31/4545 , A61K31/454 , C07D209/24 , A61K31/404
Abstract: Provided herein are small molecules that bind to ASH1L and inhibit ASH1L activity, and methods of use thereof for the treatment of disease, including acute leukemia, solid cancers and other diseases dependent on activity of ASH1L.
-
公开(公告)号:US11633490B2
公开(公告)日:2023-04-25
申请号:US17468308
申请日:2021-09-07
Applicant: The Regents of the University of Michigan
Inventor: Jolanta Grembecka , Szymon Klossowski , Jing Deng , Tomasz Cierpicki , Hao Li , Hongzhi Miao , Trupta Purohit , EunGi Kim , Dong Chen
IPC: A61K47/64 , A61K31/404 , A61K31/454 , A61K31/4545 , A61K35/02 , A61K38/45 , C07D309/24 , C07D471/04 , A61K9/00 , A61P35/02 , A61K47/54 , C07D209/24
Abstract: Provided herein are small molecules comprising a first domain that binds to ASH1L and a second domain that facilitates ASH1L degradation. In particular, ASH1L-targeting proteolysis targeting chimeras (PROTACs) and methods of use thereof for the treatment of disease (e.g., acute leukemia, solid cancers and other diseases dependent on activity of ASH1L) are provided.
-
公开(公告)号:US11110177B2
公开(公告)日:2021-09-07
申请号:US16186012
申请日:2018-11-09
Applicant: The Regents of the University of Michigan
Inventor: Jolanta Grembecka , Szymon Klossowski , Jing Deng , Tomasz Cierpicki , Hao Li , Hongzhi Miao , Trupta Purohit , EunGi Kim , Dong Chen
IPC: A61K47/64 , A61K31/404 , A61K31/454 , A61K31/4545 , A61K35/02 , A61K38/45 , C07D309/24 , C07D471/04 , A61K9/00 , A61P35/02 , A61K47/54 , C07D209/24
Abstract: Provided herein are small molecules comprising a first domain that binds to ASH1L and a second domain that facilitates ASH1L degradation. In particular, ASH1L-targeting proteolysis targeting chimeras (PROTACs) and methods of use thereof for the treatment of disease (e.g., acute leukemia, solid cancers and other diseases dependent on activity of ASH1L) are provided.
-
公开(公告)号:US11786602B2
公开(公告)日:2023-10-17
申请号:US17468308
申请日:2021-09-07
Applicant: The Regents of the University of Michigan
Inventor: Jolanta Grembecka , Szymon Klossowski , Jing Deng , Tomasz Cierpicki , Hao Li , Hongzhi Miao , Trupta Purohit , EunGi Kim , Dong Chen
IPC: A61K47/64 , A61K31/404 , A61K31/454 , A61K31/4545 , A61K35/02 , A61K38/45 , C07D309/24 , C07D471/04 , A61K9/00 , A61P35/02 , A61K47/54 , C07D209/24
CPC classification number: A61K47/64 , A61K9/0019 , A61K9/0053 , A61K31/404 , A61K31/454 , A61K31/4545 , A61K38/45 , A61K47/545 , A61K47/556 , A61P35/02 , C07D209/24 , C07D471/04 , C12Y203/02
Abstract: Provided herein are small molecules comprising a first domain that binds to ASH1L and a second domain that facilitates ASH1L degradation. In particular, ASH1L-targeting proteolysis targeting chimeras (PROTACs) and methods of use thereof for the treatment of disease (e.g., acute leukemia, solid cancers and other diseases dependent on activity of ASH1L) are provided.
-
公开(公告)号:US11147885B2
公开(公告)日:2021-10-19
申请号:US16854527
申请日:2020-04-21
Applicant: The Regents of the University of Michigan
Inventor: Jolanta Grembecka , Szymon Klossowski , Jing Deng , Tomasz Cierpicki , Hao Li , Hongzhi Miao , Trupta Purohit , EunGi Kim
IPC: C07D471/04 , A61K31/4545 , A61K31/454 , A61K31/404 , A61K47/64 , A61K9/00 , A61K38/45 , A61P35/02 , A61K47/54 , C07D209/24
Abstract: Provided herein are small molecules that bind to ASH1L and inhibit ASH1L activity, and methods of use thereof for the treatment of disease, including acute leukemia, solid cancers and other diseases dependent on activity of ASH1L.
-
公开(公告)号:US20240366774A1
公开(公告)日:2024-11-07
申请号:US18488912
申请日:2023-10-17
Applicant: The regents of the University of Michigan
Inventor: Jolanta GREMBECKA , Szymon Klossowski , Jing Deng , Tomasz Cierpicki , Hao Li , Hongzhi Miao , Trupta Purohit , EunGi Kim , Dong Chen
IPC: A61K47/64 , A61K9/00 , A61K31/404 , A61K31/454 , A61K31/4545 , A61K38/45 , A61K47/54 , A61P35/02 , C07D209/24 , C07D471/04
Abstract: Provided herein are small molecules comprising a first domain that binds to ASH1L and a second domain that facilitates ASH1L degradation. In particular, ASH1L-targeting proteolysis targeting chimeras (PROTACs) and methods of use thereof for the treatment of disease (e.g., acute leukemia, solid cancers and other diseases dependent on activity of ASH1L) are provided.
-
公开(公告)号:US20220288217A1
公开(公告)日:2022-09-15
申请号:US17504159
申请日:2021-10-18
Applicant: The Regents of the University of Michigan
Inventor: Jolanta Grembecka , Szymon Klossowski , Jing Deng , Tomasz Cierpicki , Hao Li , Hongzhi Miao , Trupta Purohit , EunGi Kim
IPC: A61K47/64 , A61K9/00 , A61K31/454 , A61K38/45 , A61P35/02 , A61K47/54 , A61K31/404 , A61K31/4545 , C07D209/24 , C07D471/04
Abstract: Provided herein are small molecules that bind to ASH1L and inhibit ASH1L activity, and methods of use thereof for the treatment of disease, including acute leukemia, solid cancers and other diseases dependent on activity of ASH1L.
-
公开(公告)号:US20190142961A1
公开(公告)日:2019-05-16
申请号:US16186012
申请日:2018-11-09
Applicant: The Regents of the University of Michigan
Inventor: Jolanta Grembecka , Szymon Klossowski , Jing Deng , Tomasz Cierpicki , Hao Li , Hongzhi Miao , Trupta Purohit , EunGi Kim , Dong Chen
IPC: A61K47/64 , A61K9/00 , A61P35/02 , A61K38/45 , A61K31/454
Abstract: Provided herein are small molecules comprising a first domain that binds to ASH1L and a second domain that facilitates ASH1L degradation. In particular, ASH1L-targeting proteolysis targeting chimeras (PROTACs) and methods of use thereof for the treatment of disease (e.g., acute leukemia, solid cancers and other diseases dependent on activity of ASH1L) are provided.
-
公开(公告)号:US12285490B2
公开(公告)日:2025-04-29
申请号:US18488912
申请日:2023-10-17
Applicant: The Regents of the University of Michigan
Inventor: Jolanta Grembecka , Szymon Klossowski , Jing Deng , Tomasz Cierpicki , Hao Li , Hongzhi Miao , Trupta Purohit , EunGi Kim , Dong Chen
IPC: A61K47/64 , A61K9/00 , A61K31/404 , A61K31/454 , A61K31/4545 , A61K38/45 , A61K47/54 , A61P35/02 , C07D209/24 , C07D471/04
Abstract: Provided herein are small molecules comprising a first domain that binds to ASH1L and a second domain that facilitates ASH1L degradation. In particular, ASH1L-targeting proteolysis targeting chimeras (PROTACs) and methods of use thereof for the treatment of disease (e.g., acute leukemia, solid cancers and other diseases dependent on activity of ASH1L) are provided.
-
公开(公告)号:US11833210B2
公开(公告)日:2023-12-05
申请号:US17504159
申请日:2021-10-18
Applicant: The Regents of the University of Michigan
Inventor: Jolanta Grembecka , Szymon Klossowski , Jing Deng , Tomasz Cierpicki , Hao Li , Hongzhi Miao , Trupta Purohit , EunGi Kim
IPC: C07D471/04 , A61K31/4545 , A61K47/64 , A61K9/00 , A61K31/454 , A61K38/45 , A61P35/02 , A61K47/54 , A61K31/404 , C07D209/24
CPC classification number: A61K47/64 , A61K9/0019 , A61K9/0053 , A61K31/404 , A61K31/454 , A61K31/4545 , A61K38/45 , A61K47/545 , A61K47/556 , A61P35/02 , C07D209/24 , C07D471/04 , C12Y203/02
Abstract: Provided herein are small molecules that bind to ASH1L and inhibit ASH1L activity, and methods of use thereof for the treatment of disease, including acute leukemia, solid cancers and other diseases dependent on activity of ASH1L.
-
-
-
-
-
-
-
-
-